Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

Share Price is delayed by 15 minutes
Get Live Data
10.50    0.00 (0.00%)
Bid:
10.00
Ask:
11.00
Spread: 1.00 (10.00%)
Market Cap: £22.91m
SOS Live PriceLast checked at - London Stock Exchange

Intraday Sosandar Share Chart

Re-pricing of Share Options

28 Dec 2012 12:00

RNS Number : 4132U
Orogen Gold PLC
28 December 2012
Β 

ο»Ώ

28 December 2012

Β 

Orogen Gold Plc

("Orogen Gold" or "the Company")

Β 

Re-pricing of Share Options

Orogen Gold Plc (ORE.L) the AIM listed European gold exploration company announces that is has re-priced the exercise price on a total of 200,000,000 share options held by directors of the Company from 0.95p per share to 0.60p per share.Β The share options are exercisable during the period 16 February 2012 and 15 February 2021.

The share options were originally granted in February 2011 at the time of the reverse takeover of Medavinci Plc by Orogen Gold Limited and after the Company's share price had recorded substantial gains associated with the reverse takeover. The re-pricing brings the strike price of the options more into line with the current market price of the shares and should now deliver appropriate incentive and reward to the Board.

The rebasing of the exercise price of the Options to Directors is a related party transaction under the AIM Rules. Where a company enters into a related party transaction the independent directors of the company are required by the AIM Rules to consult with the company's Nominated Adviser. In this case there are no independent directors and Zeus Capital, as the Company's Nominated Adviser, therefore confirms that it considers the rebasing to be fair and reasonable in so far as Shareholders are concerned.

Β 

--- ENDS ---

Β 

Β 

Enquiries:

Β 

Orogen Gold Plc

Ed Slowey, CEO

Alan Mooney, FD

Website: www.orogengold.com

Β 

Β 

+353 1662 8395

Β 

Β 

Zeus Capital Limited

Nominated Adviser and Joint Broker

Corporate Finance

Ross AndrewsAndrew Jones

Β 

Β 

+44 (0)161 831 1512

XCAP Securities Plc

Joint Broker

Jon Belliss

Β 

Β 

Β 

+44 (0) 207 101 7070

Newgate Threadneedle

Financial PR

Beth Harris

Richard Gotla

Β 

Β 

+44 (0) 207 653 9840

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBKODDCBDDCBB
Date   Source Headline
25th Jun 20261:53 pmRNSNotice of Results & Investor Presentation
24th Jun 20267:00 amRNSAppointment of Nominated Adviser and Broker
11th Jun 20261:07 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20263:36 pmRNSNotification of major holdings
1st Jun 20263:40 pmRNSTransaction in Own Shares and Total Voting Rights
11th May 20263:27 pmRNSNotification of major holdings
5th May 20268:17 amRNSHolding(s) in Company
1st May 202611:48 amRNSHolding(s) in Company
30th Apr 20261:41 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20269:25 amRNSHolding(s) in Company
21st Apr 20264:30 pmRNSHolding(s) in Company
14th Apr 20267:00 amRNSFull Year Trading Update
1st Apr 202610:31 amRNSResult of General Meeting
25th Mar 202612:00 pmRNSTransaction in Own Shares and Total Voting Rights
13th Mar 20267:00 amRNSNotice of General Meeting
13th Mar 20267:00 amRNSNotice of General Meeting
3rd Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20261:47 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20262:00 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20267:00 amRNSBoard Change
19th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jan 20262:10 pmRNSNotification of major holdings
15th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20267:00 amRNSTrading Update
6th Jan 202612:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20252:24 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20252:24 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20257:00 amRNSRestructuring of executive share incentives
12th Dec 20254:49 pmRNSNotification of major holdings
26th Nov 20253:08 pmRNSNotification of major holdings
25th Nov 20257:00 amRNSHalf Year Results
21st Nov 202511:42 amRNSNotification of major holdings
20th Nov 20257:00 amRNSNotification of major holdings
13th Nov 20257:00 amRNSNotification of major holdings
10th Nov 20254:33 pmRNSNotification of Major Holdings
29th Oct 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 202510:18 amRNSDirector/PDMR Shareholding
20th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20252:03 pmRNSHolding(s) in Company
16th Oct 202511:24 amRNSCapital Reduction - Effective
14th Oct 20254:00 pmRNSCapital Reduction - Court Approval
14th Oct 20257:00 amRNSHalf Year Trading Update
3rd Oct 202512:32 pmRNSHolding(s) in Company
2nd Oct 20255:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.